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ABSTRACT
Background : Foot ulcers and its complications are an important cause of morbidity and mortality 
in diabetes. The aim of this retrospective study is to determine the ulcer-free 
survival in diabetic foot and its relevant predictors in a cohort of diabetic patients in 
the primary health care setting.
Methods : Data of newly diagnosed diabetics (n=1121) who received treatment in five health 
centers in the district of Kuala Langat, Selangor between 1st January 1999 until the 
30th June 2008 were studied. Information was gathered by reviewing patient’s 
medical records. All patients were followed until 31st December 2008. The duration 
of ulcer-free survival was measured from the date of being diagnosed as diabetic 
until the development of the ulcer.
Results : The total incidence of diabetic foot ulcer was 9.9% (n=111), with an average annual 
incidence of 1%. The total incidence of amputation was 1.2%. Mean age of being 
diagnosed having diabetic was 52+10.7 year old and mean age of being diagnosed 
having diabetic foot ulcer was 54.68+10.16 year old. The mean for overall ulcer-free 
survival was 99 months (95%CI:96-102). Male gender (LR=6.56; p=0.01), smokers 
(LR=3.94; p=0.04), low body mass index (LR=4.45; p=0.03), impaired renal 
function (LR=5.17; p=0.02) and long duration between follow-up (LR=25.10; 
p<0.0005) predicted the ulcer-free survival.  However, with Cox’s Proportional 
Hazard Regression analysis factors independently associated to ulcer-free survival 
were impaired renal function (HR=1.65)(95%CI:1.09,2.46), poor lipid control 
(HR=2.36)(95%CI:1.03, 5.41) and duration of follow-up more than six months 
(HR=4.74)(95%CI:2.28,9.86). Other factors studied were not significant.
Conclusion : In conclusion, about 1% of primary care health center-based diabetic patients 
developed new ulcers each year. Renal profile and lipid profile can be used as a 
predictor to ulcer-free survival for diabetic foot ulcer in the primary health care 
setting. All patients must be given the appropriate duration of follow-up which 
should not exceed more than six months with emphasis on defaulter tracing to 
increase the number of patients free from diabetic foot ulcer.
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INTRODUCTION
Foot ulcers and their complications are another 
important cause of morbidity and mortality in 
diabetes. It is also associated with infection 
that leads to tissue necrosis and end-up with 
amputation1. Clinical studies have consistently 
identified measures of peripheral neuropathy 
as predicting diabetic foot ulceration, with 
some evidence for other association such as 
peripheral vascular disease, limited joint 
mobility, foot deformities, duration of 
diabetes, improper foot wear, trauma, injury 
due to self treatment, fissure, poor hygiene and 
infection2,3,4. 
The yearly incidence of diabetic foot 
ulcer is 1-4% and the prevalence is 4-15%3,5,6. 
The lifetime prevalence of amputation in 
diabetes is about 6-43% which is 10-20 times 
higher than community without diabetes7. This 
is due to the non-healing ulcer, where the rates 
of recurrence are very high8. This type of 
patients has a high mortality following 
amputation, ranging between 39% and 80% 
within 5 years5. However, compliance and 
simple preventive foot care program in primary 
health care center reduces the incidence of 
diabetic foot ulcer9 and thus reduces the risk of 
amputation and death following these 
complications.
Most research focuses on specific 
groups of diabetic patients. Indeed such studies 
are invariably case-controlled in design, or if 
prospective analyses, assess relatively small, 
clinic base groups of patients subject to 
selection bias1,8. Relevant risk factors for foot 
ulceration and their ulcer-free survival in 
diabetic patients receiving care in community 
health centers have not yet been determined in 
Malaysia, even though these are the diabetic 
patients who are, or should be, screened by 
family medicine specialist, medical and health 
officers, medical assistant and practice nurses. 
In this retrospective study, a large 
cohort of diabetic patients receiving health care 
in Kuala Langat health centers were studied to 
determine the baseline of yearly incidence of 
foot ulceration and the predictor of ulcer-free 
survival.
METHODS
All patients diagnosed with Type 1 or Type 2 
diabetes according to World Health 
Organization (WHO) criteria between 1st
January 1999 and 30th June 2008 were targets 
in five health care centers of Sijangkang, Telok 
Datok, Kg. Bandar, Bukit Changgang and 
Jenjarom of Kuala Langat, Selangor. 
Information was gathered by reviewing 
patient’s diabetic record book (green book) and 
outpatient records. Direct discussions with 
clinic health officers were held when any 
doubts occur. Otherwise, a telephone call or 
direct interview was used to confirm any 
information with patients or their family 
members.
At baseline, all cases were screened to 
determine the date of diabetes diagnosis. All 
cases diagnosed from 1st January 1999 to 30th
June 2008 (inclusion period) and of Malaysian 
nationality were short listed. Cases that 
fulfilled the exclusion criteria were withdrawn. 
The exclusion criteria were patient, who 
already developed foot ulcer upon being 
diagnosed as diabetic, ever had foot ulcers in 
the past or had undergone amputation at any 
level due to any cause. Cases were censored if 
they died, lost to follow-up during the study 
period or did not develop foot ulcer before the 
study end.
All patients were followed-up until 
31st December 2008. The duration of ulcer-free 
survival was measured from the date of being 
diagnosed as diabetic until the foot ulcer 
developed. The definition of ulcer in this study 
was any full thickness skin defect at least class 
I Megitt Wagner classification that required 
more than two weeks for healing3. Ulcer 
presentation was determined from the 
statement in patient’s diabetic book records. 
The actual date of diagnosis either for diabetes 
or foot ulcer was noted. Nevertheless, the 
appointment date was choose if there was no 
actual date recorded with assumption that the 
ulcer was developed between the 
appointments.
Risk factors identified were recorded 
for all selected cases. Demographic and 
lifestyle characteristic include treatment center, 
age at being diagnosed diabetes, gender, 
ethnicity, level of education, marital status and 
smoking status. Other factors studied were 
presence of hypertension, presence of 
cardiovascular disease, body mass index 
(BMI), glycaemic control (HbA1c or fasting 
blood sugar), lipid control, renal function, 
statin use, ulcer etiology (presence of 
neuropathy, ischemia or neuroischemia) and 
duration between follow-up.
Age was categorized into three 
groups: less than 30, 30-65 and 65 or older. 
Three major ethnic groups in Malaysia were 
taken into account which was Malays/ 
Bumiputra, Chinese and Indian/ Sikh. BMI 
was calculated by dividing weight (measured
in kilograms) by the square of height 
(measured in meters) and was further 
categorized into non obese and obese. A 
respondent was considered obese if BMI was 
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27.5kg/m2 and higher. Parameter for diabetic 
monitoring was categorized according to 
clinical practice guidelines by Ministry of 
Health Malaysia (Table 1). Ethical approval 
was obtained from the research ethics 
committee National University of Malaysia 
(UKM) and National Institute of Health 
Malaysia. This study also registered to the 
National Medical Research Registry (NMRR) 
of Malaysia.
Table 1   Parameter for diabetic monitoring in Malaysia
Category
Normal Abnormal
1. Glycaemic Control
HbAIc
Fasting Blood Glucose
Random Glucose 
2. Lipid
Cholesterol total
Triglyseride
HDL
LDL
3. Body Mass Index
4. Renal Function
Macro/microalbuminuria
Serum Urea
Serum Creatinine
<6.5%
4.4-6.1mmol/L
4.4-8.0mmol/L
<4.5mmol/L
<1.7mmol/L
>1.1mmol/L
<2.6mmol/L
<23kg/m2
-ve
2.5-6.7mmol/L
70-150umol/L
>6.5%
>6.1mmol/L
>4.4-8.0mmol/L
>4.5mmol/L
>1.7mmol/L
<1.1mmol/L
>2.6mmol/L
  >23kg/m2
+ve
>6.7mmol/L
>150umol/L
Source: Ministry of Health Malaysia 2004
Statistical Analysis
Data were analyzed using the SPSS version 
12.0. The relationship between baseline 
variables and incidence of new diabetic foot 
ulceration was assessed by Kaplan-Meier 
Survival Curve for each variable separately. 
The 10-year ulcer-free survival rates were also 
determined using the Kaplan-Meier survival 
curve. The equality of survivor functions of the 
different groups was tested using the Log Rank 
test. Then, Cox’s Proportional Hazard 
Regression analysis was carried out for 
variables that gave a p value less or equal to 
0.1 with Kaplan-Meier Log Rank test to 
determine the subset of independent predictors 
and the hazard ratio of developing foot ulcers. 
RESULTS
A total of 4288 diabetic patients’ medical 
records were screened from five health centre 
in Kuala Langat District of Selangor. Then 
1258 cases which diagnosed and registered as 
diabetics from 1st January 1999 until 30th June 
2008 were selected. A total of 137 were 
dropped according to the exclusion criteria; i) 
there is a foot ulcer upon diagnosis, ii) ever 
had diagnosed foot ulcer previously or iii) 
patient had undergone amputation of any 
cause. At the end only 1121 cases were 
selected as respondent.
Jenjarom Health Centre contributed 
the largest number of diabetic patients 
diagnosed during the inclusion period which 
was 350 cases (29%). This was followed by 
Telok Datok with 323 cases (29%), Kg. 
Bandar with 198 cases (18%), Bukit 
Changgang with 145 cases (13%) and the least, 
Sijangkang with 125 cases (11%). Majority of 
the respondent, 94.9% (n=1064) were on oral 
hypoglycemic agent (OHA), whereas only 
5.1% (n=57) were prescribed insulin or 
combination of both insulin and OHA.
Baseline characteristic and other 
variables were given in table 2. Of the 1121 
respondents, 58.2% (n=652) were female and 
41.8% (n=469) were male. Diagnosis of 
diabetes were more common at the age of 30 to 
65 year old (86.8%; n=973), followed by aged 
above 65 year old (11.6%; n=130) and aged 
below 30 year old (1.6%; n=18). Mean age at 
being diagnosed having diabetic was 52+10.7 
year old. The youngest was 18 year old and the 
eldest was 85 year old. Meanwhile, the mean 
age of being diagnosed having diabetic foot 
ulcer was 54.68+10.16 year old. The youngest 
was 29 year old and the eldest was 85 year old. 
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Of the respondents in this study, 
61.8% (n=693) were Malays/ Bumiputra, 
24.3% (n=272) were Indian/ Sikh and 13.9% 
(n=156) were Chinese. Main ethnic in most of 
the health centre were Malays/ Bumiputra. In 
Telok Datok Health Centre, Indian ethnicity 
(47.7%; n=154) was more than Malays/ 
Bumiputra (42.7%; n=138) and Chinese (9.6%; 
n=31). Whereas in Jenjarom Health Centre, the 
Chinese ethnicity (32.7%; n=108) was more 
than Indian/ Sikh (24.5%; n=81).
In terms of highest formal education 
level, 55.8% (n=626) had achieved secondary 
school, 27.4% (n=307) had primary or no 
formal education and 13.2% (n=148) had enter 
or completed tertiary education. Of all 
respondents, 91.7% (n=1016) were married 
and 8.3% (n=92) were single.
The total incidence of diabetic foot 
ulcer within 10 years in the district was 9.9% 
(n=111), with an average annual incidence of 
1%. Meanwhile, the total incidence of 
amputation was 1.2%, in which 12.6% from 
overall patients who developed foot ulcers. 
Patients start to developed ulcer less than 6 
months after being diagnosed as diabetics. The 
mean for overall ulcer-free survival was 99 
months (95%CI:96,102). Figure 1 shows the 
cumulative ulcer-free survival within 10 year 
after diabetes had been diagnosed. There were 
more diabetics developed foot ulcers after 
eight years as compared to the earlier year.
Figure 1  Overall ulcer-free survival in 10 years
Table 2 presents the detailed information on 
respondent characteristics and their association 
with the diabetic foot ulcer development. The 
prevalence of foot ulcer among male (12.4%) 
were higher than female (8.1%) although there 
were more female than male in this study 
(χ2=5.49; p=0.02). The ages at being diagnosed 
as neither diabetics nor foot ulcers were not 
different, as well as glycaemic control. 
However, female body mass index were found 
to be higher than male which was 28.49+5.22 
kg/m2 and 27.31+4.71 kg/m2 respectively.
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Table 2     Distribution of patients according to sociodemography, behaviour, co-morbidity and 
treatment
Variables
Patients with 
diabetic foot 
ulcers
Patients without 
diabetic foot 
ulcers Total
(n)
Chi 
Square
(χ2)
P value
No. of 
samples
(n)
%
No. of 
samples
(n)
%
1. Health Centre
     Sijangkang
     Telok Datok
     Kg. Bandar
     Bukit Changgang
     Jenjarom
     (n=1121)
12
28
19
18
34
9.6
8.7
9.6
12.4
10.3
113
295
179
127
296
90.4
91.3
90.4
87.6
89.7
125
323
198
145
330
1.67 0.79
2. Gender
    Male
    Female
    (n=1121)
58
53
12.4
8.1
411
599
87.6
91.9
469
652
5.49 0.02
3. Age at being diagnosed 
diabetes
     < 65 year old
     > 65 year old
     (n=1121)
100
11
10.1
8.5
891
119
89.9
91.5
991
130
0.34 0.56
4. Ethnicity
    Malays/ Bumiputra
    Chinese
    Indian/ Sikh
    (n=1121)
42
31
38
9.0
11.1
10.1
424
249
337
91.0
88.9
89.9
466
280
375
5.55 0.06
5. Formal Education
    Nil/ Primary
    Secondary
    Tertiary
    (n=1083)
37
54
16
12.1
8.6
10.7
270
572
133
87.9
91.4
89.3
307
627
149
2.88 0.24
6. Marital Status
    Married
    Unmarried
    (n=1108)
103
8
10.1
8.7
913
84
89.9
91.3
1016
92
0.61 0.79
7. Smoking Status
    Smoker
    Non Smoker
    (n=1095)
36
70
12.2
8.8
259
730
87.8
91.3
295
800
2.94 0.09
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8. Co-Morbidity
    Hypertension
             Yes
             No
             (n=1121)
    Cardiovascular 
Dis.
             Yes
             No
             (n=1121)
60
51
24
87
9.2
10.8
14.5
9.1
589
421
141
869
90.8
89.2
85.5
90.9
649
472
165
956
0.75
4.68
0.39
0.03
9. Parameter of Diabetic Control
    Glycaemic Control
             Normal
             Abnormal
             (n=1121)
    Body Mass Index
             Non Obese
             Obese
             (n=1000)
    Lipid Profile
             Normal
             Abnormal
             (n=1067)
    
    Renal Function
             Normal
             Abnormal
             (1081)
22
89
61
39
7
98
43
64
7.7
10.7
12.1
7.9
5.5
10.4
7.3
13.1
265
745
445
455
120
842
549
425
92.3
89.3
87.9
92.1
94.5
89.6
92.7
86.9
285
836
506
494
127
940
592
489
2.16
4.81
3.04
10.19
0.14
0.03
0.08
0.01
10. Duration Between Follow-up
       < 3 months
       3-6 months
       >6 months
       (n=1121)
3
47
11
11.3
7.7
31.4
417
569
24
88.7
92.3
68.6
470
616
35
22.63 <0.0005
11. Foot Ulcer 
Aetiology
       Neuropathy
       Ischemia
       Neuroischemia
       (n=349)
45
1
6
14.4
10.0
30.0
273
9
14
85.6
90.0
70.0
319
10
20
3.92 0.14
12. Statin Group User
       Yes
       No
       (n=1121)
37
74
8.8
10.6
384
626
91.2
89.4
421
700
0.89 0.34
Male was having shorter time to 
develop foot ulcer after diagnosed being 
diabetic as compared to female. Their mean 
ulcer-free survival was 96 months 
(95%CI:92,100) and 102 months 
(95%CI:99,105) respectively, where the Log 
Rank (LR) was 6.46 and p-value of 0.01. Other 
sociodemographic factor such as place of 
treatment, aged at being diagnosed diabetes, 
ethnicity, levels of highest formal education, 
marital status and smoking status were not 
associated to the development of diabetic foot 
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ulcer. There was also no difference between 
groups of these risk factors on having a shorter 
time to developed foot ulcer.
However, those of Indian/ Sikh 
ethnicity were found to have diabetic and ulcer 
at an earlier age.  The Indian/ Sikh were 
diagnosed as diabetic at the mean age of 
49.10+10.98 year old. It was followed by the 
Malays/ Bumiputra with mean age 
52.42+10.26 year old and Chinese with mean 
age 55.31+11.24 year old. The mean age of 
being diagnosed ulcer for Indian/ Sikh were 
54.68+10.16 year old, followed by 54.85+9.76 
year old for Malays/ Bumiputra and 61.15+8.6 
year old for Chinese.
About 1095 records stated their 
smoking status, where 73.1% (n=800) were 
non smokers and 26.9% (n=295) were 
smokers. Of the 295 smokers, 60.9% (n=273) 
were males. Prevalence of smoking among 
female was only 3.4%. Smoking status alone 
was not associated with the development of 
diabetic foot ulcer. However, smokers were 
developed ulcers earlier than non smokers 
(Figure 2). The mean ulcer-free survival for 
smokers was 95 months (95%CI:90,101), 
whereas mean survival for non smokers was 
101 months (95%CI:99,104) with Log Rank 
3.94 and p-value of 0.04.
Figure 2    Diabetic-foot-ulcer-free survival according to smoking status
The presence of cardiovascular disease in 
diabetic patient had an association with the 
foot ulcer development (χ2=4.68; p=0.03). 
Prevalence of ulcer in the presence of 
cardiovascular disease were 14.5%, whereas in 
the absence of cardiovascular disease the 
prevalence were much lower (9.1%). But, there 
was no difference between presence and 
absence of cardiovascular disease on having a 
shorter time to develop foot ulcer (LR=0.49; 
p=0.48). Mean ulcer-free survival in the 
presence of cardiovascular disease was 97 
months (95%CI:91,103) and mean ulcer-free 
survival without cardiovascular disease was 
100 months (95%CI:98,103).
Most of the respondents were 
overweight and obese. Mean BMI fall under 
obese category. Mean BMI for diabetics with 
ulcer was 27.06+5.35kg/m2, whereas mean 
BMI for diabetics without ulcer was 
28.09+4.99kg/m2. There was also an 
association between body mass index and 
development of foot ulcer (χ2=4.81; p=0.03). 
Non obese respondent was more prone to 
develop ulcer as compared to obese 
respondent, in which the prevalence of ulcer 
were 12.1% and 7.9% respectively. Non obese 
patient developed ulcer earlier than obese 
patients (LR=4.45; p=0.03). Mean ulcer-free 
survival for non obese was 96 months 
(95%CI:92,101) and mean ulcer-free survival 
for obese patients was 103 months 
(95%CI:100,106). 
More than half respondents had 
uncontrolled blood lipid level. About 88.1% 
(n=940) unable to control their total 
cholesterol or triglyceride or both. There was 
only 11.9% (n=127) had a normal lipid level. 
Prevalence of ulcer among uncontrolled lipid 
level was 10.4%, whereas only 5.5% among 
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controlled lipid level (χ2=3.04; p=0.08).  
Diabetics with uncontrolled lipid level 
developed ulcer faster (mean survival 99 
months; (95%CI:96,102)) than diabetics with 
controlled lipid level (mean survival 107 
months; (95%CI:102,112)) however it was not 
statistically significant (LR=3.06; p=0.08).
Figure 3    Diabetic-foot-ulcer-free survival according to lipid control
Among this respondent, 37.5% were using 
statin group for dyslipidemia treatment. 
Prevalence of ulcer among statin group user 
was 8.8% and 10.6% among non statin group 
user (χ2=0.89; p=0.34). There was also no 
difference between this two groups in having 
shorter time to develop foot ulcer (LR=2.95; 
p=0.13). Mean ulcer-free survival for statin 
group user was 103 months (95%CI:99,106) 
and mean for non statin group user was 98 
months (95%CI:94,101).
Many diabetics were having renal 
impairment (45.2%), abnormal urea, excess 
creatinine and albuminuria. There were 
significant association between renal function 
and development of foot ulcer (χ2=10.19; 
p=0.001). Diabetics with renal impairment was 
prone to develop foot ulcer earlier as compared 
to diabetics without renal impairment 
(LR=5.17; p=0.02). Mean ulcer-free survival 
for patients with renal impairment was 97 
months (95%CI:93,101), whereas 102 months 
(95%CI:99,106) in patients without renal 
impairment.
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Figure 4   Diabetic foot ulcer-free survival according to renal function
Mean duration between follow-up among 
diabetics with ulcer found to be longer 
(3.16+2.65 months) as compared to diabetics 
without ulcer (2.84+1.44 months) and the 
difference was statistically significant 
(t=2.007; p=0.04). The prevalence of ulcer 
among patients with duration between follow-
up more than six months was 31.4%, followed 
by duration between follow-up less than 3 
months 11.3% and duration between follow-up 
3-6 months 7.7%.  This difference was also 
statistically significant (χ2=22.63; p<0.0005).
Patient who had infrequent follow-up 
was having shorter time to develop foot ulcer. 
Within 5 year after diabetes diagnosis had been 
made, 50% of them developed ulcers. Mean 
ulcer-free survival among them was 62 months 
(95%CI:51,73) and median 60 months 
(95%CI:42,77). This was followed by the 
group with duration of follow-up less than 3 
months with mean ulcer-free survival 97 
months (95%CI:93,101) and the least was 
group with duration of follow-up three to six 
months with mean ulcer-free survival 103 
months (95%CI:100,106) and these difference 
were statistically significant (LR=25.10; 
p<0.0005). 
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Figure 5  Diabetic-foot-ulcer-free survival according to duration of follow-up
The significant variables influencing ulcer-free 
survival were smoking status, body mass 
index, renal function and duration between 
follow-up. Six variables were entered into the 
Cox’s Proportional Hazard model; including 
variables that give the p value less than 0.1 in 
the Kaplan-Meier Log Rank test which were 
gender and lipid control. The body mass index 
variable was not included as there was many 
missing data that might influence the results. 
Only 7.4% (83 cases) respondent will be 
dropped from the analysis if this variable not 
included. Whereas, it will increase to 17.3% 
(194 cases) if this variable included. The total 
number of cases included in the final model
was 1038 (92.6%), where there were 101 of 
foot ulcer cases and 83.6% of censored cases.
Patients with duration of follow-up 
more than six months were 4.74 times 
(95%CI:2.28,9.86) faster from patients with 
duration of follow-up 3 to 6 months to develop 
diabetic foot ulcer (p<0.005). Patients with 
abnormal lipid profile will develop ulcer 2.36 
times (95%CI:1.03,5.41) faster than patients 
with normal lipid profile (p=0.04). Diabetics 
with renal impairment were 1.65 times 
(95%CI:1.10,2.46) having shorter time to 
develop an ulcer as compared to the diabetics 
with normal renal function (p=0.02). Other 
factors; gender, smoking status, statin use and 
duration of follow-up less than 3 months were  
not the main predictor for the ulcer-free 
survival.
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Table 3    Kaplan-Meier Log Rank Results
Variables
No. of 
Sample
(N)
Diabetic 
Foot Ulcer 
Cases (n)
Survival Mean
(95% CI)
Log Rank
(LR)
P value
1. Health Centre:
        Sijangkang
     Telok Datok
     Kg. Bandar
     Bkt Changgang
     Jenjaro
1121
125
323
198
145
330
111
12
28
19
18
34
102 (99, 105)
96 (90,102)
102 (98,106)
102 (96,107)
94 (86,102)
96 (91,102)
4.02 0.40
2. Gender:
        Male
        Female
1121
469
652
111
58
53
96 (92,100)
102 (99,105)
6.56 *0.01
3. Age at Diagnosis 
DM
        <65 year old
        >65 year old
1121
991
130
111
100
11
99 (96,102)
103 (97,109)
0.73 0.39
4. Ethnicity:
        Malays/ Bumiputra
     Chinese
     Indian/ Sikh
1121
466
280
375
111
42
31
38
100 (97,104)
97 (92,103)
100 (96,104)
0.97 0.61
5. Formal Education
    Nil/ Primary
    Secondary
    Tertiary
1083
307
627
149
106
37
54
16
98 (93,103)
101 (97,104)
98 (90,105)
1.33 0.51
    6. Marital Status
     Married
     Unmarried
1108
92
1016
111
8
103
96 (89,104)
99 (97,102)
0.01 0.91
7. Smoking Status
        Smoker
     Non Smoker
1095
295
800
106
36
70
95 (90,101)
101 (99,104)
3.94 *0.04
8. Co-Morbidity
    Hypertension:
    Yes
    No
    Cardiovascular Dis.:
     Yes
     No
1121
649
472
1121
165
956
111
60
51
111
24
87
101 (97,104)
98 (94,102)
97 (91,103)
100 (98,103)
0.82
0.49
0.36
0.48
9. Parameter of  
Diabetic              
Glisemik Control:
    Normal
    Abnormal
    Body Mass Index:
     Non Obese
     Obese
Continue from page 54
Control
1121
285
836
1000
506
494
111
22
89
100
61
39
102 (98,107)
99 (96,102)
96 (92,101)
103 (100,106)
1.35
4.45
0.25
*0.03
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    Lipid Profile:
    Normal
    Abnormal
    Renal Function:
    Normal
    Abnormal
1067
127
940
1081
592
489
105
7
98
107
43
64
107 (102,112)
99 (96,102)
102 (99,106)
97 (93,101)
3.06
5.17
0.08
*0.02
10. Duration Between 
       Follow-up
       <3 months
       3-6 months
       >6 months
1121
470
616
35
111
53
47
11
97 (93,101)
103 (100,106)
62 (51,73)
25.10 *<0.0005
   11. Foot Ulcer 
Aetiology
      Neuropathy
      Ischemia
      Neuroischemia
348
319
10
20
52
46
1
6
96 (92,101)
83 (71,96)
81 (60,102)
4.13 0.13
   12. Statin Group User
         Yes
         No
1121
420
701
111
37
74
103 (99,106)
98 (94,101)
2.95 0.09
There was no sign of colinearity 
effect that may increase or decrease the effect 
size; all standard error lies between 0.01 and 
5.0, hazard ratio value for all predictors were 
not prominent and the matrix not showing any 
potential effect. The results of this analysis 
were shown in Table 4. Other factors studied 
were found to be not significant.
Table 4    The Cox’s Proportional Hazard Regression Analysis Results
Variable
Standard 
Error
Hazard Ratio 
95% Confidence 
Interval
P value
1. Gender
        Female
        Male 0.25
1.00
1.61 0.98-2.65 0.06
2. Smoking Status
        Non Smokers
        Smoker 0.27
1.00
1.09 0.65-1.86 0.73
3. Serum Lipid
        Normal
        Abnormal 0.42
1.00
2.36 1.03-5.41 *0.04
4. Renal Function
        Normal
        Abnormal 0.21
1.00
1.65 1.02-2.34 *0.04
5. Statin Group
        Yes
        No 0.21
1.00
1.40 0.92-2.13 0.11
6. Duration of Follow-
up
        3-6 month
        < 3 month
        > 6 month
0.21
0.37
1.00
1.46
4.74
0.96-2.24
2.28-9.86
0.07
<0.0005
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DISCUSSION
The overall incidence and average annual 
incidence of diabetic foot ulceration in the 
diabetic cohort in 10 years was about 10% and 
1% respectively. Prospective cohort estimation 
on the annual incidence of diabetic foot ulcers 
in England was 2.2%3. Similar incidence found 
in Netherlands which was 1.2-3.0%12. A 
retrospective cohort study of 8905 diabetic 
patients by Ramsey determined similar average 
annual incidence of foot ulceration (2%), 
whereas the incidence in a population-based 
sample of older-onset diabetic patients was 
higher (2.6%) 13. 
The overall mean ulcer-free survival 
for diabetic patients in Kuala Langat was 8.3 
years. This was similar to patients in 
Netherlands which was 8.9 years and their 
amputation-free survival was 10.2 years12. The 
strongest independent predictors for ulcer-free 
survival were abnormal lipid level, renal 
impairment and duration of follow-up more 
than 6 months. 
Abnormal lipid profile is not the 
predictor for development of new foot 
ulceration but it speed-up the time for ulcer 
development by three times. Nearly 40% 
diabetics with abnormal lipid profile was using 
statin group to control dyslipidemia. Statin 
group use was only introduced about 7 to 8 
years ago in the district. In this study, statin 
group found to reduce the risk for foot ulcer 
and maintain the state of ulcer-free longer. 
After 7 years of diabetes diagnosis, there were 
no more foot ulcer cases in statin group user. 
Nevertheless, the non statin group users were 
continuously developed foot ulcers. If we 
prolonged the study period, the results 
probably might become significant as the 
difference become more prominent. 
Basically statin group will cause 
vasodilatation of the blood vessels and 
improve circulation especially to the vital 
organ and distal end14,15. Thus, reduce the risk 
of atherosclerosis, artery blockage and 
ischemia and indirectly reduce the risk of foot 
ulcer16. However, we were unable to 
demonstrate the temporal cause-effect 
association properly as the date of statin started 
in each users was not included in this study.
Almost half of the patients in Kuala 
Langat were having renal impairment, which 
was quite similar to American diabetics 
(40%)17. In this study, renal impairment was 
the predictor for diabetic foot ulcer16. Similar 
findings by Fernando showed that there was a 
strong association between microalbuminuria 
and foot ulcer22. This study revealed that 
diabetics with renal impairment were nearly 
twice as likely to have shorter time to 
developed foot ulcer as diabetics without renal 
impairment. This finding was similar to 
diabetic community in England which was 
2.55 times faster6. Both study showed a tight 
confidence interval secondary to large sample 
size. Present of renal impairment give a 
general picture of changes in retina and intima 
layer of the vessels. Therefore, 
macroalbuminuria or macroalbuminuria is also 
a sign of other vascular disease such as 
peripheral vascular disease that may aggravate 
the development of foot ulcers18,19.
The most common duration between 
follow-up in the district was between 3 to 6 
months. This current study found that patients 
with duration between follow-up more than 6 
months were 5 times faster to get diabetic foot 
ulcer as compared to patient with the usual 
follow-up. This was the people that defaulted 
follow-up for many reasons. When there was 
little monitoring, probability of non 
compliance to treatment high, delay in 
detection of complications and no specific 
prompt treatment given.
A surprising result was patient with 
frequent follow-up was 1.4 times faster to get 
foot ulcer as compared to diabetics with 3 to 6 
months follow-up. This seems to suggest that 
frequent attendance may have directly caused 
foot ulcers, but this is most unlikely. The 
results probably reflects that ulcers occur more 
frequently in patients, whom healthcare 
providers have identified as being “foot at 
risk” and they were given more frequent 
appointment for monitoring. However, it is not 
the main predictor for foot ulceration as it 
becomes insignificant when other factor were 
controlled.
More than 2/3 of the defaulters were 
unable to control their glycaemic level. Almost 
half of them was having high blood pressure 
but never diagnosed nor treated and 40% of the 
hypertensive was poorly controlled. Many 
patients from this group also had renal 
impairment (40%) and high lipid level (80%). 
Moreover, 90% of the defaulters with 
abnormal lipid level were not using any 
antilipid agent including statin group. 
Although the problem were not much 
difference from the group with duration of 
follow-up less than 3 months and between 3 to 
6 months, their progress were easy to monitor 
and specific early management can be given.
It was noticeable that prevalence of 
ulcer in this current study was higher among 
male, while majority respondents were female. 
Study in Kuala Lumpur Hospital and Dundee 
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also has similar results, where male were two 
times higher to get foot ulcer1620,21. This may 
mean that female patients develop fewer foot 
ulcers. However, Kumar in 1994 found that 
both male and female have similar risk to get 
foot ulcer22.  Male in Kuala Langat was 1.6 
times to get faster diabetic foot ulcer as 
compared to female but gender was not a 
strong predictor in this study. Male community 
in England was significantly 1.4 times to get 
faster diabetic foot ulcer3.  This is because they 
were using a large number of sample (n=9710) 
that gave a tight confidence interval. However, 
Boyko in 2006 found that there was no 
difference in getting faster foot ulcer23. Both 
male and female had their own other risk 
factors. Prevalence of smoking is high in male 
which is a known risk factor for ulcer. 
Whereas female prone to get sole ulcer which 
is associated with higher BMI21.
Knowledge of ethnic difference in a 
multi-ethnic nation such as Malaysia is still not 
much known. But, this knowledge will help 
medical staffs manage their patients better with 
respect to prevention of complications24. 
Indian/ Sikh ethnicity was found to have 
diabetic and ulcer at an early age as compared 
to Malay/ Bumiputra and Chinese. This finding 
is not congruent to study by Hong in Toa 
Payoh Polyclinic in Singapore where Malays 
were diagnosed early and followed by Indian 
and Chinese26.  Bear in mind that Malays in 
Malaysia is the majority ethnic group but in 
Singapore they are the minority group. Ethnic 
differences in diabetic foot ulcer are most 
probably due to both genetic and 
environmental factors. Environmental changes 
in general able to modify the susceptibility of 
patients to complications of diabetes.
There was no significant association 
between age at being diagnosis as diabetes and 
foot ulcer in this current study. Patients who 
diagnosed at early age presented with more 
severe symptom that make it possible for early 
detection. Therefore they are more susceptible 
to get foot ulcer earlier. Whereas, elderly 
diabetics has undergone few changes such as 
foot deformity, increase blood flow resistant, 
reduce activities, eye problem, lonely and 
suffer from other medical problems. Foot ulcer 
development is more depending on duration of 
diabetes but not the age at diagnosis27. 
Nevertheless, Abbott showed an association 
between age and foot ulcer25. 
Most independent predictors of 
development of foot ulcer and ulcer-free 
survival have been identified previously by 
other studies, but there were some surprising 
findings. We found that lower body mass 
index is the predictor for ulcer development 
and ulcer-free survival. This might be due to 
gluconeogenesis and lipolysis secondary to 
long term uncontrolled diabetes, so that these 
kinds of patient were leaner. Otiniano in 2003 
also found that obesity alone does not explain 
the excess prevalence and incidence of 
diabetes and its complication26. Previous 
studies reported that the propensity of leanness 
was related to diabetes complications and 
mortality.
Blood pressure did not have any 
effect on duration of ulcer development 
although more than half of the diabetics were 
also hypertensive. This might be because there 
were 1/3 of the patients with blood pressure 
above 130/80mmHg but never been diagnosed. 
Moreover a lot of hypertensive in diabetes 
(more than half) was unable to control their 
blood pressure even with medication and some 
were fluctuating.
In this study diabetic control was 
optimal only in 1/3 of the cases. Mean HbA1c 
was above normal which was 8.5%. Although 
most of the study revealed that HbA1c level is 
related to diabetic foot ulcer and other 
complications, it has not to our knowledge 
been independently associated with a higher 
risk of foot ulcer or speed-up the development 
of foot ulcer. Boyko in 1999 and 2006 in 
Seattle also found similar results where HbA1c 
were not associated independently with 
diabetic foot ulcers23,27.
Patients with diabetes commonly had 
a terminal illness that included several renal 
failure and either severe heart disease or 
stroke. Heart attack is the most commonly 
reported cause of death in diabetic Mexican 
American in Hispanic Established Population 
for the Epidemiological Study of the elderly in 
America26. Over 15% of patients with diabetes 
had a history of heart attack and 11% had a 
history of stroke. Both are known to have
significant impact on mortality and disability, 
particularly in patients with diabetes.
Neuropathy prevalence in our 
population is about 28%, more or less similar 
to the rate in England population (22%). 
Previous studies revealed that neuropathy has a 
greater effect on diabetic foot ulcer but it was 
not true in this study. Diabetics with 
neuropathy were getting ulcer earlier than 
diabetics without neuropathy23,28. Whereas, 
ischemia might delay the healing process due 
to lack of nutrient and oxygen secondary to 
poor blood circulation1,27. The combination of 
both neuropathy and ischaemia will further 
shortened the duration for ulcer development1.
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Strength and Limitation of Study
In this study a mass screening was undertaken 
to examine a large sample of patient’s record 
(n=4288) from the primary health care center. 
Effort were made to minimize selection bias 
for this cohort by screening all diabetic 
patient’s record as they attended diabetes 
review in various health care centers in the 
district; Sijangkang, Telok Datok, Kg. Bandar, 
Bukit Changgang and Jenjarom. This kind of 
study of truly primary health care-based 
sample of newly diagnosed diabetics will in 
principle produce an unbiased estimate of 
overall incidence and ulcer-free survival if 
complete follow-up and data collection can be 
achieved.
In special clinic-based and hospital-
based studies, referral bias is likely to produce 
higher morbidity and mortality rates than in 
primary health care-based and community-
based studies. Furthermore data from 
prevalence studies may be misleading because 
selective survival of diabetic patients with a 
more favorable risk factors profile. The very 
severe and complicated diabetics may have 
died earlier that we cannot include them in 
prevalence study. Prevalence study, case-
control and cohort are only interested in the 
final event, whether there is event or no event. 
Whereas the variable of interest in this survival 
study is the time from diabetes diagnosis until 
an ulcer occurs. This survival study was able to 
demonstrate the temporal association between 
risk factors and the development of foot ulcer. 
Moreover, the measurement of incidence can 
be done.
Despite all health centers initially 
agreeing to take part, we screened at only 4288 
cases of the 5 clinics in 6 months due to time 
constraints. Determination of accurate diabetes 
population figures was also a problem, due to 
general lack of accurate registers at this time. 
We did, however estimates of the total diabetic 
population (2008) from various sources (Third 
National Health and Morbidity Survey of 
Malaysia, Population Survey 2000 of Statistic 
Department, Diabetic Registry of Kuala Langat 
Health Centre), and 4288 cases equated of 
approximately 18.8% of all patients in the 
district. From the sheer size of the study, this 
large patient cohort is probably a reasonable 
representation of the primary-health-care-
based diabetes population in Kuala Langat 
District of Selangor, Malaysia.
This survival study was able to deal 
with unequal observation time of the subjects 
under study that makes it incompatible with 
other conventional study. Moreover, it is 
capable to adapt with censored data that makes 
it possible to use all data in the analysis. 
Although patients are no longer followed 
because of death, loss of follow-up for 
unknown reason or no ulcer observed before 
study ends, the time that is known until the 
respondent are last observed are still can be 
used in the analysis. Because, these censored 
data still carry important information despite 
their incompleteness. For each respondent, at 
least we know that respondent’s time from 
diabetes diagnosis to foot ulcer event is greater 
than duration on observation.
Potential confounders of the 
multivariate analysis cannot be ignored. Ulcer 
occurrence would also be influence by other 
potential risk factors not measured in this study 
such as healthcare provision, patient behavioral 
factors, compliance to treatment, foot care and 
hygiene, improper foot wear, diet, daily 
activities, exercise and others. 
We also have not been able to report 
on the provision of primary health care 
services in each health centre. However it is a 
common knowledge that the process of 
healthcare in the district is variable in quality 
and generally of lower standard of supervision 
as compared to specialist clinic in the hospital 
that possibly influencing ulcer outcomes. 
Where patient receive well-organized and 
regular care with rapid referral to appropriate 
specialist multidisciplinary teams before 
problem occurs, ulceration can be prevented 
and morbidity reduced27.
We were also unable to review the 
death certificates to find out other underlying 
cause of death in diabetic patients. Several 
studies that reviewed death certificates found 
that it was very common that death certificates 
of patients with diabetes did not mention 
diabetes as an underlying cause. Most of 
patients records and registries are not up-to-
date and do not stated the cause of default. 
These are important because death is being the 
competing risk to occurrence of foot ulcer 
because death preclude subsequent foot ulcer. 
Death and diabetic foot ulcer also cannot 
consider as statistically independent unless all 
deaths arise from completely unrelated 
condition such as motor vehicle accidents30. 
Because of this reason, we are unable to study 
this competing risk. 
Other issue in this study was 
information bias from secondary data. We use 
a secondary data from diabetic book records 
with no clinical reevaluation in which may 
exposed to information bias. Some factors will 
changed during the study period such as 
smoking status, marital status, glycaemic 
control, lipid control, renal profile and others. 
However, we have tried to minimized the 
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problem by discussing any doubt with clinic’s 
officer, confirmation via phone call or direct 
interview if patient available in the clinic. 
Moreover, we have tried to use the mean of all 
possible continuous measures that may 
influence the development of ulcer.
CONCLUSION
We have demonstrate that about 1% of a large 
cohort of diabetic patients seeing in the 
primary health care setting will develop new 
foot ulceration each year. About 10% 
developed foot ulcers within 10 year. 
Furthermore, we now have important 
confirmation that a baseline screening 
measures before diabetic registration; gender, 
presence of cardiovascular disease, smoking 
status, body mass index, renal profile and lipid 
profile can be used to identify the “high risk” 
patients and predict the onset of diabetic foot 
ulcer events. 
These current findings underscore the 
importance of enhanced efforts to improve 
diabetes care as soon as possible after diabetes 
diagnosis as foot ulcer developed less than 6 
months after diagnosis of diabetes has been 
made. A further prospective survival study of 
other important risk factors but not included in 
this study will be very meaningful such as 
dietary, compliance, foot care, foot hygiene, 
clinical signs and others.
All patients should be screened 
regularly for foot complications, given foot 
care leaflets and useful telephone numbers and 
contact addresses so that in future foot 
problems could be addressed immediately, and 
were referred when appropriate for podiatry 
and peripheral vascular tests. Thus 
empowering the patient, easing access to 
appropriate care, improving attitudes and 
motivation potentially may influence future 
ulceration rates for community based patients.
Diabetic screening program also must 
be improved as the early development of 
diabetic foot ulcer in this study is a sign of late 
diagnosis. Another important factor is to 
review all patients with an adequate follow-up 
which is less than 6 months. We must also 
improve and strengthened the defaulter tracing 
in non-communicable disease in able to 
prolong the ulcer-free period in diabetics.
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